Journal of Drugs in Dermatology reports VISIA a beneficial tool for patient education in dermatology and aesthetic practices.
The November, 2014 issue of the Journal of Drugs in Dermatology reports the results of a survey involving twenty-one women at a dermatology practice. Each subject underwent a facial skin analysis using the VISIA Complexion Analysis System, and was then asked to complete a questionnaire about the experience. Tabulating the results, 86% of the participants reported that the VISIA analysis helped them understand their initial concern, and the same number reported that the analysis brought other skin problems to their attention. 62% of the subjects responded that they would prefer to go to a practice with VISIA rather than one without VISIA. And 100% said they would recommend VISIA analysis to others.
Recent News in In The Media
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- Canfield’s VECTRA® WB360 recently installed at Allegheny Health Network Cancer Institute
- Dr. Sherina Balaratnam discusses with Francesca Ogiermann-White why Canfield’s VISIA® is an essential part of all her consultations
Most Recent News
- Advancing Skin Screenings: Dr. Charles E. Mount III and Director Howard Edington, MD Discuss VECTRA® WB360 at AHN Cancer Institute with CBS News
- National Doctors’ Day, Spotlighting Glynis Ablon, MD, FAAD
- Dr. Robyn Siperstein, M.D., discusses Canfield’s revolutionary AI & AR technology and its role in consultations in MedEsthetics Magazine
- VISIA®’s 5th Consecutive Win as Favorite Diagnostic Tool in Dermascope’s Aestheticians’ Choice Awards!